SCHEMBL14657207

SCHEMBL14657207

O=C(O)c1cc(-n2c3ccccc3c3cc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)ccc32)c(C(=O)O)cc1-n1c2ccccc2c2cc(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3)ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
KDM4E B2RXH2 3/20 0.50
ATM Q13315 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PTGER4 P35408 1/20 0.44
KMT2A Q03164 1/20 0.43
TSPO P30536 1/20 0.41
HDAC4 P56524 1/20 0.41
NOTUM Q6P988 1/20 0.40
GAA P10253 1/20 0.40
GFER P55789 1/20 0.40
TSHR P16473 1/20 0.40
FOLH1 Q04609 1/20 0.40
EDNRA P25101 2/20 0.39
PTGES O14684 1/20 0.39
EDNRB P24530 1/20 0.39
MYC P01106 1/20 0.38
FABP3 P05413 1/20 0.38
FABP4 P15090 1/20 0.38
FABP5 Q01469 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14656964 0.86 NR4A2 (0.51) ALDH1A1KDM4EATML3MBTL1PTGER4
SCHEMBL14657482 0.85 ALDH1A1 (0.73) ALDH1A1KDM4EATML3MBTL1GAA
SCHEMBL2790066 0.84 KDM4E (0.51) ALDH1A1KDM4EATML3MBTL1PTGER4
SCHEMBL25557692 0.84 L3MBTL1 (0.62) ALDH1A1KDM4EATML3MBTL1PTGER4
SCHEMBL11981026 0.83 L3MBTL1 (0.72) ALDH1A1KDM4EATML3MBTL1PTGER4
SCHEMBL14900748 0.83 L3MBTL1 (0.72) ALDH1A1KDM4EATML3MBTL1PTGER4
SCHEMBL29354385 0.83 L3MBTL1 (0.72) ALDH1A1KDM4EATML3MBTL1PTGER4
SCHEMBL29387946 0.83 L3MBTL1 (0.72) ALDH1A1KDM4EATML3MBTL1PTGER4
SCHEMBL11981068 0.83 L3MBTL1 (0.72) ALDH1A1KDM4EATML3MBTL1PTGER4
SCHEMBL5999723 0.83 L3MBTL1 (0.72) ALDH1A1KDM4EATML3MBTL1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9422287-B2 Bridged triarylamines and -phosphines as materials for electronic devices MERCK PATENT GMBH (DE) 2016-08-23 US disclosed
US-20130026422-A1 BRIDGED TRIARYLAMINES AND -PHOSPHINES AS MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2013-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130026422-A1 BRIDGED TRIARYLAMINES AND -PHOSPHINES AS MATERIALS FOR ELECTRONIC DEVICES TEC, PNMT, TES ALDH1A1 612/4885KDM4E 2344/4885ATM 1707/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.